The number of treatment options available to those with psoriasis has nearly doubled in the past few years. And the number of options is continuing to increase as dermatologists study combinations of new therapies and previously available treatments. Some of these combinations are improving patients' quality of life as they prove to be more effective and offer longer periods of remission. 2001 Annual Meeting in Washington, D.C., dermatologist Mark Lebwohl, MD, Professor and Chairman, Department of Dermatology, Mount Sinai School of Medicine, New York, talked about new treatments for psoriasis, including those still in development, as well as the possibility of mixing treatments for greater results. Psoriasis is a recurring, noncontagious skin disorder that is characterized by raised, thickened patches of red skin covered with silvery-white scales.
Psoriasis can range in severity and affect any part of the body, including the nails and scalp.
It is estimated that over 7 million Americans have psoriasis, with more than 150,000 new cases reported each year. New Psoriasis Treatments Clobetasol propionate, one of the most effective topical corticosteroids for the treatment of psoriasis, has recently been approved as a foam specifically for the treatment of scalp psoriasis. The foam penetrates the skin easily, enhancing the effectiveness of the treatment. Tacrolimus ointment has recently been approved for the treatment of atopic dermatitis and does show promise for the treatment of psoriasis on the face and other areas prone to sensitivity and side effects when treated with other topical agents. However, the treatment does not seem effective for the treatment of thick plaque psoriasis.